A detailed history of High Note Wealth, LLC transactions in Repligen Corp stock. As of the latest transaction made, High Note Wealth, LLC holds 26 shares of RGEN stock, worth $3,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 24 8.33%
Holding current value
$3,902
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$108.89 - $145.23 $217 - $290
2 Added 8.33%
26 $3,000
Q1 2025

May 01, 2025

BUY
$127.24 - $174.24 $1,399 - $1,916
11 Added 84.62%
24 $3,000
Q4 2024

Apr 01, 2025

BUY
$123.41 - $160.92 $1,604 - $2,091
13 New
13 $1,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.33B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track High Note Wealth, LLC Portfolio

Follow High Note Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Note Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Note Wealth, LLC with notifications on news.